TSXV:NCX.V: $

Building a company around our commitment to exploration and development

Investor Information

Financial Overview

There are currently 104,988,200 common shares issued and outstanding.

Stock Options

As at August 29, 2017 the following stock options are outstanding:

Expiry Date Number Outstanding Exercise Price
November 30, 2017 370,000 0.17
June 28, 2018 200,000 0.10
February 11, 2019 1,375,000 0.05
June 24, 2020 1,545,000 0.05
May 4, 2021 1,565,000 0.05
June 28, 2021 75,000 0.05
January 9, 2022 2,550,000 0.17
7,680,000  0.10

Share purchase warrants

At August 29, 2017 the following common share purchase warrants were outstanding:

Expiry Date Number Outstanding Exercise Price
June 6, 2018 2,500,000 0.05
May 5, 2019 3,474,158 0.25
5,974,158  0.17

Financial Statements

Fiscal Year 2017
2nd Quarter Report for the period ended June 30, 2017 FS MD&A
1st Quarter Report for the period ended March 31, 2017 FS MD&A
Fiscal Year 2016
Audited Annual Financial Statements for the year ended December 31, 2016 FS MD&A
3rd Quarter Report for the period ended September 30, 2016 FS MD&A
2nd Quarter Report for the period ended June 30, 2016 FS MD&A
1st Quarter Report for the period ended March 31, 2016 FS MD&A
Fiscal Year 2015
Audited Annual Financial Statements for the year ended December 31, 2015 FS MD&A
3rd Quarter Report for the period ended September 30, 2015 FS MD&A
2nd Quarter Report for the period ended June 30, 2015 FS MD&A
1st Quarter Report for the period ended March 31, 2015 FS MD&A
Fiscal Year 2014
Audited Annual Financial Statements for the year ended December 31, 2014 FS MD&A
3rd Quarter Report for the period ended September 30, 2014 FS MD&A
2nd Quarter Report for the period ended June 30, 2014 FS MD&A
1st Quarter Report for the period ended March 31, 2014 FS MD&A
Fiscal Year 2013
Audited Annual Financial Statements for the year ended December 31, 2013 FS MD&A
3rd Quarter Report for the period ended September 30, 2013 FS MD&A
2nd Quarter Report for the period ended June 30, 2013 FS MD&A
1st Quarter Report for the period ended March 31, 2013 FS MD&A
Fiscal Year 2012
Audited Annual Financial Statements for the year ended December 31, 2012 FS MD&A
3rd Quarter Report for the period ended September 30, 2012 FS MD&A
2nd Quarter Report for the period ended June 30, 2012 FS MD&A
1st Quarter Report for the period ended March 31, 2012 FS MD&A
Fiscal Year 2011
Audited Annual Financial Statements for the year ended December 31, 2011 FS MD&A

Contact Investor Information